Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Trends: CVS Health Insider Receives Stock Award, Buy Trend Intact

06/02/2021 | 05:02pm EDT


ę MT Newswires 2021
All news about CVS HEALTH CORPORATION
07/28CVS HEALTH : opens Workforce Innovation and Talent Center in Pittsburgh
PU
07/22CVS HEALTH CORPORATION : Ex-dividend day for
FA
07/21FACTBOX-Companies pay billions of dollars over role in U.S. opioid crisis
RE
07/21CVS HEALTH CORPORATION : to Hold Second Quarter 2021 Earnings Conference Call
PR
07/21Drugmakers, pharmacies next targets for U.S. opioid settlements
RE
07/20New York, drug distributors reach $1.18 billion opioid settlement as national..
RE
07/16WALGREENS BOOTS ALLIANCE : Target removes J&J sunscreens from stores, website
RE
07/15Pharmacies pull J&J sunscreens off shelves after carcinogen found in some spr..
RE
07/15MARKET CHATTER : CVS Health Reportedly Halts Sales of Sun-Care Products After J&..
MT
07/14Over two million Americans sign up for Obamacare under Biden drive
RE
More news
Financials (USD)
Sales 2021 282 B - -
Net income 2021 8 233 M - -
Net Debt 2021 48 413 M - -
P/E ratio 2021 13,4x
Yield 2021 2,40%
Capitalization 110 B 110 B -
EV / Sales 2021 0,56x
EV / Sales 2022 0,52x
Nbr of Employees 256 500
Free-Float 75,6%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | MarketScreener
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 83,30 $
Average target price 95,94 $
Spread / Average Target 15,2%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President